Author: Chih Wei Teng

Woman lying in hospital bed. Image credit: Sharon McCutcheon on Unsplash

Adding CAR-T to Cart: What are the hurdles impacting patient access to cell and gene therapies?

Chih Wei Teng | August 21, 2019

Innovative and curative treatments continually push the boundaries of treating known medical conditions. However, as the world changes gears, shifting from small molecules to cellular and gene therapies,

Sky reflected in corner of a glass skyscraper

News

A reflection of the 11th Business of Regenerative Medicine

Chih Wei Teng | October 22, 2018

It was a sunny Philadelphia that greeted the 11th Business of Regenerative Medicine Symposium. Hosted at the University of Pennsylvania’s Similow Center for Translational Research, the two-day symposium

CCRM_au

@CCRM_au

SAVE THE DATE! The inaugural Business of Regenerative Medicine Asia Pacific will be held on the 20th & 21st April 2020 at King & Wood Mallesons in Sydney's CBD. Contact Chih Wei Teng or Tamara Treleaven for more info. #BRMAP #regenmed #commercialisation #savethedate pic.twitter.com/GYfRNBwPyL

2:29 am · November 19, 2019

CCRM_au

@CCRM_au

Did you know that we have a newsletter? Subscribe via bit.ly/34WmWpF to get the latest #regenmed & CCRM news PING @MTPConnect_AUS @AusBiotech @VicGovAu @GregHuntMP @StemCellsAus @AusStemCell @CCRM_ca pic.twitter.com/SZvTh3l7Y1

9:09 am · November 13, 2019

CCRM_au

@CCRM_au

The key to the #commercialization journey is actually in developing relationships with stakeholders through an understanding of priorities, rather than trying to be an expert in all areas. #regenmed #commercialization @MTPConnect_AUS pic.twitter.com/JuhiR5QsBA

8:36 am · November 11, 2019

CCRM_au

@CCRM_au

We are pleased to launch CCRM Australia Attract alongside @StVincentsMelb! This unit will facilitate and provide specialised business, regulatory & IP services along with #commercialisation and #technology expertise to the 🇦🇺 #regenmed sector! More info: ccrmaustralia.com.au/2019/11/… pic.twitter.com/49Kov46sDF

5:50 am · November 7, 2019

CCRM_au

@CCRM_au

And that's a wrap! Thank you to everyone that attended #Ausbio19 and especially those that participated in the #RegenMed stream on Wednesday! An extra special thank you to the @VicGovAu for giving us the opportunity to join this year's pavillion! See you next year! @AusBiotech pic.twitter.com/sITIzotWBu

1:57 am · November 1, 2019

CCRM_au

@CCRM_au

Did you know that we have a newsletter? Subscribe via bit.ly/332MUrb to get the latest #regenmed & CCRM news PING @MTPConnect_AUS @AusBiotech @VicGovAu @GregHuntMP @StemCellsAus @AusStemCell @CCRM_ca pic.twitter.com/Ucu7ggvgni

8:35 am · October 31, 2019

CCRM_au

@CCRM_au

More & more novel #celltherapies are beginning to emerge from later-stage trials, which begs the question - how much can co-payments increase in response to expensive treatments and should there be a cap on the number of novel treatments approved per year? bit.ly/36hb3MA

7:00 pm · October 30, 2019

CCRM_au

@CCRM_au

Our CEO and Chair of this afternoon's #AusBio19 #RegenMed - International Perspectives session, @silvio12, with speakers (L to R): Dr Donghoon Oh, Stemlab Inc.; @CLuxmanan, University of Otago and Dr Yoshitsugu Shitaka, Forum for Innovative Regenerative Medicine (FIRM). #BioTech pic.twitter.com/OmFqGm01F5

5:26 am · October 30, 2019

CCRM_au

@CCRM_au

REMINDER: @CCRM_au are presenting this year's #RegenMed stream starting at 3:30 pm in room 208. The session, chaired by our CEO @silvio12 , will discuss the advances & opportunities in #RegenerativeMedicine from an international perspective. #AusBio19 @AusBiotech pic.twitter.com/SYfKcxK17G

3:40 am · October 30, 2019

CCRM_au

@CCRM_au

REMINDER: @CCRM_au are presenting this year's #RegenMed stream starting at 1:30 pm in room 208. The session, chaired by Dr Dawn Driscoll from @CellTherapies_ , will discuss the advances & opportunities in #RegenerativeMedicine in Australia. #AusBio19 @AusBiotech pic.twitter.com/gJfyyDJ1fE

1:15 am · October 30, 2019